Table 7 Chlamydia trachomatis infections and prostate cancer
Study | Country | Method | Prostate cancer | Prostate non cancer controls | P value |
|---|---|---|---|---|---|
Dillner 1998 [106] | Finland | Serology | 18/165 11% | 31/290 11% | 0.948Â ns |
Rosenblatt 2001 [81] | US | Self report | 5/748 1% | 9/694 1% | 0.229Â ns |
Antilla 2005 [108] | Finland, Sweden, Norway | Serology | 55/738 8% | 238/2271 11% | 0.030 s Control > cancer |
Sutcliffe 2007 [109] | US | Serology | 28/655 4% | 24/655 4% | 0.990Â ns |
Huang 2008 [87] | US black US white | Serology | 37/103 36% 86/765 11% | 131/367 36% 89/915 10% | 0.977Â ns 0.362Â ns |
Dennis 2009 [98] | US | Serology | 39/267 15% | 31/267 12% | 0.369Â ns |
Hrbacek 2011 [88] | Czech Republic | Serology | 18/329 6% | 12/105 11% | 0.054 s Control > cancer |
Lumme 2016 [110] | Finland | Serology | 51/6699 7% | 224/2132 11% | 0.002 s Control > cancer |